Skip to main content

Table 2 Clinicopathological and genetic features of current case and previously reported cases of primary pulmonary myxoid sarcoma

From: Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion: a case report and review of the literature

Case No. (Ref. No.)

Age

sex

EBC (+/−)

Size (cm)

Pathological features

IHC

Molecular genetics

Treatment

Follow-up (months)

1(3)

27

F

EBC+

4

Ill-defined nodules of myxoid stroma, interweaving cords of small uniform, round or slightly elongated cells with eosinophilic cytoplasm, occasional mitoses.

Vimentin+, CK-, S100-, desmin-, SMA-, CD34-.

ND

Surgery

NEOD after 36

2(3)

43

F

EBC+

13

Ill-defined nodules of myxoid stroma, interweaving cords of small uniform, round or slightly elongated cells with eosinophilic cytoplasm, occasional mitoses.

Vimentin+, CK-, S100-, desmin-, SMA-, CD34-.

ND

Surgery

NEOD after 6

3(2)

27

F

EBC+

4

Well circumscribed, lobulated, reticular network with delicate lacelike strands and cords of cells within prominent myxoid stroma, tumor cells showed no or minimal atypia.

CK-, S100-, desmin-.

EWSR1-CREB1 fusion

Surgery

NEOD after 180

4(2)

33

F

EBC+

3.5

Lobulated, reticular network with delicate lacelike strands and cords of cells within prominent myxoid stroma, tumor cells showed mild to moderate atypia.

CK-, S100-, desmin-.

EWSR1-CREB1 fusion

Surgery

NEOD after 144

5(2)

45

F

EBC+

1.5

Circumscribed, lobulated, cellular sheets or patternless, tumor cells showed mild to moderate atypia.

S100 focal+, CK-, desmin-, p63-.

Negative

Surgery

NEOD after 12

6(2)

36

F

NR

NR

Circumscribed with fibrous pseudocapsule. Reticular network with delicate lacelike strands and cords of cells within prominent myxoid stroma, tumor cells showed minimal atypia.

CK-, EMA-, TTF1-, S100-, desmin-.

Negative

Surgery

DOD with brain metastases a few months after diagnosis

7(2)

32

F

EBC+

NR

Lobulated. Reticular network with delicate lacelike strands and cords of cells within prominent myxoid stroma, tumor cells showed moderate atypia.

CK-, EMA-,S100-, desmin-.

EWSR1-CREB1 fusion

Surgery

NR

8(2)

28

M

EBC+

2.8

Infiltrative and lobulated, cellular sheets or patternless, tumor cells showed mild to moderate atypia,

EMA weak+, CK-, TTF1-, S100-, HMB45-, melan A-, desmin-.

EWSR1-CREB1 fusion

Surgery

Left renal metastasis, alive and well after 3 years.

9(2)

67

M

EBC+

2.8

Well circumscribed and lobulated, reticular network with delicate lacelike strands and cords of cells within a prominent myxoid stroma., tumor cells showed minimal atypia.

EMA weak+, CK-, TTF-1-, S100-, desmin-.

EWSR1-CREB1 fusion

Surgery

NR

10(2)

68

F

EBC+

2.0

Well circumscribed and lobulated, reticular network with delicate lacelike strands and cords of cells within a prominent myxoid stroma, tumor cells showed moderate to marked atypia.

EMA weak+, CK-, p63-, TTF-1-, S100-, desmin-.

Negative

Surgery

NR

11(2)

63

F

EBC+

NR

Lobulated, cellular sheets or patternless, tunor cells showed mild to minimal atypia.

EMA weak +, CK-, TTF-1-, S100-, HMB45-, melan A-, desmin-.

EWSR1-CREB1 fusion

Surgery

NEOD after 48

12(2)

51

M

NR

2.0

Well circumscribed and lobulated, reticular network with delicate lacelike strands and cords of cells within a prominent myxoid stroma, tumor cells showed mild to moderate atypia.

NR

EWSR1-CREB1 fusion

Surgery

NR

13(5)

31

M

EBC+

2.7

Well circumscribed, reticular cords of oval, short spindle or polygonal cells with mild atypia, rare mitotic figures, an abundant myxoid stroma, scattered lymphoplasmacytic infiltrates.

Vimentin+, EMA focal+, CK-,

TTF-1-, napsin A-, S-100-, CD34-, desmin-, SMA-, CD10-, p63-, calponin- caldesmon-, c-kit-,

HMB-45-, synaptophysin-, GFAP-

EWSR1-CREB1 fusion

Surgery

NEOD after 68

14(6)

66

F

EBC+

4

Polygonal to spindled cells, reticular network with delicate lacelike strands and cords of cells within a prominent myxoid stroma, tumor cells showed mild atypia.

EMA focal+, CK-, p63-, S100-, desmin-.

EWSR1-CREB1 fusion

Surgery

NR

15(6)

28

M

NR

8.5

Lobulated, biphasic, ~ 40% composed of myxoid pools, exuberant fibroinflammatory reaction with confluent plasma cells, tumor cells showed moderate atypia.

Desmin+, EMA focal+, CK-, p63-. S100-.

Negative

Surgery

NR

16(6)

28

M

EBC+

6

Infiltrative, focal necrosis and inflammation, tumor cells showed severe atypia.

EMA focal+, CK-, p63-, S100-.

EWSR1 rearrangement,. but not CREB1

Surgery

NR

17(7)

26

M

EBC+

9

Multinodular, reticular network with delicate lacelike strands and cords of cells within prominent myxoid stroma, tumor cells showed mild to moderate atypia.

Vimentin+, EMA focal+, CD99 focal weak+, SMA-, desmin-, caldesmon-H-, calponin-, S100-, CK-, CD31-, CD34-, p63-, CD56-, synaptophysin-.

EWSR1-CREB1 fusion

Surgery

NEOD after 19

18(7)

49

F

EBC-

4

Multinodular, reticular network with delicate lacelike strands and cords of cells within prominent myxoid stroma, tumor cells showed mild to moderate atypia.

Vimentin+, EMA focal+, CD99 focal weak+, SMA focal+, desmin-, caldesmon-H, calponin-, S100-, CK-, CD31-, CD34-, p63-, CD56-, synaptophysin-.

EWSR1-CREB1 fusion

Surgery

NEOD after 117

19(7)

54

F

EBC+

4.5

Multinodular, reticular network with delicate lacelike strands and cords of cells within prominent myxoid stroma, tumor cells showed moderate atypia.

Vimentin+, EMA focal+,

CD99 focal+, SMA-, desmin-, caldesmon-H-, calponin-, S100-, CK-, CD31-, CD34-, p63-, CD56-, synaptophysin-.

EWSR1-CREB1 fusion

Surgery

NEOD after 152

20(7)

65

M

EBC+

13

Multinodular, reticular network with delicate lacelike strands and cords of cells within prominent myxoid stroma, tumor cells showed mild atypia.

Vimentin+, EMA focal+,

CD99 focal+, SMA-, desmin-, caldesmon-H-, calponin-, S100-, CK-, CD31-, CD34-, p63-, CD56-, synaptophysin-.

EWSR1-CREB1 fusion

Surgery

Metastasis to contralateral lung, NEOD 72 months after removal of metastasis.

21(8)

29

F

EBC-

3

Well circumscribed, short spindle, ovoid or stellate cells in reticular network, myxoid stroma, lymphoplasmacytic infiltration, tumor cells showed mild atypia.

Vimentin+, EMA+. SMA-, SMMHC-, calretinin-, TTF-1-, CK-, p63-, S-100-, CD34-, CD56-.

EWSR1-CREB1 fusion

Surgery

NEOD after 17

22(4)

80

F

EBC+

NR

Multinodular, spindle cells arranged in reticular pattern within prominent myxoid stroma, tumor cells showed moderately atypia

Vimentin+, EMA focal+. CK-, S100-, HMB45-, CD31-, CD34-, SMA-, caldesmon-H-, desmin-, GFAP-.

EWSR1-CREB1 fusion

Surgery

NEOD after 36.

23(9)

32

F

NR

3.5

Well-delineated lobulated, anastomosing cords and small nests of epithelioid cells admixed with stellate cells in chondromyxoid matrix.

Vimentin+, CD68 weak+, CD163 weak+, synaptophysin weak+. CK-, EMA-, calponin-, GFAP-, SMA-, desmin-, caldesmon-H-, S-100-, HMB-45-, CD34-, CD31-, chromogranin-.

EWSR1-CREB1 fusion

Surgery

NEOD after 96.

24(10)

21

F

PA/EBC-

NR

Polypoid tumor, trabecular networks, rare solid areas, tumor cells showed oval nuclei and eosinophilic cytoplasm,

CK weak+, SMA+, INI1-, EMA-, S100-, desmin-, ERG-, MDM2-, CDK4-.

EWSR1-CREB1 fusion

Surgery

NEOD after 38

25(11)

48

M

NR

14

Bland looking medium-sized oval to round epithelioid cells arranged in prominent reticular and microcystic lace-like chordoid pattern in highly myxoid stroma.

Vimentin+, CD10 focal+、EMA focal+, CK-, TTF-1-, ERG-, CD31-, p63-, desmin-, SMA-, S100-, CD34-, CD30- , MUC4-, TLE1-, STAT6-.

Negative

Surgery

NEOD after 23

26 (our case)

45

F

EBC-

2.1

Well circumscribed, multinodular, reticular network of delicate lace-like cellular strands and cords in abundant myxoid stroma, chondrocyte or physaliferous-like tumor cells with mild atypia.

Vimentin+, EMA+, CK-, TTF-1-, CAM5.2-, S-100-, calponin-, SMA-, desmin-, ALK-, CD31-, CD34-.

EWSR1-CREB1 fusion

Surgery

NEOD after 38

  1. F female, M male, EBC+/− endobronchial component involved (+) or not involved (−). IHC immunohistochemical stains, ND not done, NR not reported, PA pulmonary artery, DOD died of disease, NEOD no evidence of disease, CK cytokeratin(s), EMA epithelial membrane antigen, SMA smooth muscle actin, SMMHC smooth muscle myosin heavy chain, TTF-1 thyroid transcription factor-1